Analyzing AdaptHealth (NASDAQ:AHCO) & Amedisys (NASDAQ:AMED)

AdaptHealth (NASDAQ:AHCO) and Amedisys (NASDAQ:AMED) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.


This table compares AdaptHealth and Amedisys’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
AdaptHealth N/A -42.67% 1.17%
Amedisys 6.50% 22.41% 10.67%

Volatility & Risk

AdaptHealth has a beta of -0.03, suggesting that its stock price is 103% less volatile than the S&P 500. Comparatively, Amedisys has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and recommmendations for AdaptHealth and Amedisys, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AdaptHealth 0 0 6 0 3.00
Amedisys 0 3 11 0 2.79

AdaptHealth presently has a consensus target price of $24.33, suggesting a potential upside of 5.66%. Amedisys has a consensus target price of $236.21, suggesting a potential downside of 0.58%. Given AdaptHealth’s stronger consensus rating and higher probable upside, research analysts clearly believe AdaptHealth is more favorable than Amedisys.

Valuation and Earnings

This table compares AdaptHealth and Amedisys’ top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
AdaptHealth $529.64 million 3.67 -$15.00 million $0.30 76.77
Amedisys $1.96 billion 3.94 $126.83 million $4.40 54.00

Amedisys has higher revenue and earnings than AdaptHealth. Amedisys is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

12.4% of AdaptHealth shares are owned by institutional investors. Comparatively, 89.7% of Amedisys shares are owned by institutional investors. 10.9% of AdaptHealth shares are owned by company insiders. Comparatively, 2.8% of Amedisys shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.


Amedisys beats AdaptHealth on 10 of the 14 factors compared between the two stocks.

AdaptHealth Company Profile

AdaptHealth, LLC distributes home medical equipment. The Company offers mobility products, respiratory therapy, non- invasive ventilation, nutrition supplies, ocean home health products, sleep therapy supplies, bed lifts, seat lift chairs, and bath aids. AdaptHealth, LLC was founded in 2012 and is based in Phoenixville, Pennsylvania.

Amedisys Company Profile

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, social workers, and aides for its patients to complete their important personal tasks. The Hospice segment offers care that is designed to provide comfort and support for those who are dealing with a terminal illness, including heart disease, pulmonary disease, Alzheimer's, HIV/AIDS, and cancer. The Personal Care segment provides assistance for patients with the activities of daily living. As of February 27, 2019, the company owned and operated 472 care centers in 38 states. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with's FREE daily email newsletter.